KRW 4160.0
(-1.42%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 11.39 Billion KRW | 0.06% |
2022 | 11.38 Billion KRW | 172.25% |
2021 | 4.18 Billion KRW | 47.23% |
2020 | 2.84 Billion KRW | 2.34% |
2019 | 2.77 Billion KRW | 7.28% |
2018 | 2.58 Billion KRW | 0.0% |
2017 | - KRW | 0.0% |
2016 | - KRW | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 13.03 Billion KRW | -0.63% |
2024 Q1 | 13.11 Billion KRW | 15.1% |
2023 Q1 | 13.56 Billion KRW | 19.15% |
2023 Q4 | 11.39 Billion KRW | -25.14% |
2023 Q3 | 15.21 Billion KRW | 1.43% |
2023 Q2 | 15 Billion KRW | 10.6% |
2023 FY | 11.39 Billion KRW | 0.06% |
2022 Q4 | 11.38 Billion KRW | 10.4% |
2022 Q2 | 5.63 Billion KRW | 4.83% |
2022 Q1 | 5.37 Billion KRW | 28.61% |
2022 Q3 | 10.31 Billion KRW | 82.9% |
2021 Q4 | 4.18 Billion KRW | 4.86% |
2021 Q3 | 3.98 Billion KRW | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
HLB Pharmaceutical Co., Ltd | 20.85 Billion KRW | 45.376% |
CMG Pharmaceutical Co., Ltd. | 15.87 Billion KRW | 28.234% |
Celltrion Pharm, Inc. | 100.42 Billion KRW | 88.654% |
Huons Global Co., Ltd. | 121.81 Billion KRW | 90.647% |
DongKook Pharmaceutical Co., Ltd. | 138.34 Billion KRW | 91.764% |
Enzychem Lifesciences Corporation | 14.94 Billion KRW | 23.768% |
Humedix Co., Ltd. | 28.62 Billion KRW | 60.198% |
Boditech Med Inc. | 31.6 Billion KRW | 63.948% |
EuBiologics Co., Ltd. | 13.34 Billion KRW | 14.601% |
FutureChem Co.,Ltd | 1.37 Billion KRW | -728.915% |
Huons Co., Ltd. | 76.59 Billion KRW | 85.126% |
AptaBio Therapeutics Inc. | - KRW | -Infinity% |